Galectin-3-independent Down-regulation of GABABR1 due to Treatment with Korean Herbal Extract HAD-B Reduces Proliferation of Human Colon Cancer Cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Many efforts have shown multi-oncologic roles of galectin-3 for cell proliferation, angiogenesis, and apoptosis. However, the mechanisms by which galectin-3 is involved in cell proliferation are not yet fully understood, especially in human colon cancer cells. Methods: To cluster genes showing positively or negatively correlated expression with galectin-3, we employed human colon cancer cell lines, SNU-61, SNU-81, SNU-769B, SNU-C4and SNU-C5 in high-throughput gene expression profiling. Gene and protein expression levels were determined by using real-time quantitative polymerase chain reaction (PCR) and western blot analysis, respectively. The proliferation rate of human colon cancer cells was measured by using a 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)assay. Results: Expression of γ-aminobutyric acid B receptor 1(GABABR1) showed a positive correlation with galectin-3 at both the transcriptional and the translational levels. Downregulation of galectin-3 decreased not only GABABR1expression but also the proliferation rate of human colon cancer cells. However, Korean herbal extract, HangAmDan-B (HAD-B), decreased expression of GABABR1 without any expressional change of galectin-3, and offset γ-aminobutyric acid (GABA)-enhanced human colon cancer cell proliferation. Conclusions: Our present study confirmed that GABABR1expression was regulated by galectin-3. HAD-B induced galectin-3-independent down-regulation of GABABR1, which resulted in a decreased proliferation of human colon cancer cells. The therapeutic effect of HAD-B for the treatment of human colon cancer needs to be further validated.
Abstract
Objectives: Many efforts have shown multi-oncologic roles of galectin-3 for cell proliferation, angiogenesis, and apoptosis. However, the mechanisms by which galectin-3 is involved in cell proliferation are not yet fully understood, especially in human colon cancer cells. Methods: To cluster genes showing positively or negatively correlated expression with galectin-3, we employed human colon cancer cell lines, SNU-61, SNU-81, SNU-769B, SNU-C4and SNU-C5 in high-throughput gene expression profiling. Gene and protein expression levels were determined by using real-time quantitative polymerase chain reaction (PCR) and western blot analysis, respectively. The proliferation rate of human colon cancer cells was measured by using a 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT)assay. Results: Expression of γ-aminobutyric acid B receptor 1(GABABR1) showed a positive correlation with galectin-3 at both the transcriptional and the translational levels. Downregulation of galectin-3 decreased not only GABABR1expression but also the proliferation rate of human colon cancer cells. However, Korean herbal extract, HangAmDan-B (HAD-B), decreased expression of GABABR1 without any expressional change of galectin-3, and offset γ-aminobutyric acid (GABA)-enhanced human colon cancer cell proliferation. Conclusions: Our present study confirmed that GABABR1expression was regulated by galectin-3. HAD-B induced galectin-3-independent down-regulation of GABABR1, which resulted in a decreased proliferation of human colon cancer cells. The therapeutic effect of HAD-B for the treatment of human colon cancer needs to be further validated.
참고문헌 (32)
- Barondes SH., "Galectins. Structure and function of a large family of animal lectins", J Biol Chem, 269(33), pp.20807~0810 (1994)
- Gong HC., "The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells", Cancer Res, 59(24), pp.6239~6245 (1999)
- Herrmann J., "Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase", J Biol Chem, 268(35), pp.26704~6711 (1993)
- Yang RY., "Galectins in cell growth and apoptosis", Cell Mol Life Sci, 60(2), pp.267~276 (2003)
- Inohara H., "Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion", Cancer Res, 55(15), pp.3267~3271 (1995)
- Inohara H., "Galectin-3 stimulates cell proliferation", Exp Cell Res, 245(2), pp.294~302 (1998)
- Nangia-Makker P., "Galectin-3 induces endothelial cell morphogenesis and angiogenesis", Am J Pathol, 156(3), pp.899~909 (2000)
- Fukumori T., "Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer", Cancer Res, 66(6), pp.3114~3119 (2006)
- Joo HG., "Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes", J Leukoc Biol, 69(4), pp.555~564 (2001)
- Yoshii T., "Galectin-3 maintains the transformed phenotype of thyroid papillary carcinoma cells", Int J Oncol, 18(4), pp.787~792 (2001)
- Yoo BC., "Galectin-3 stabilizes heterogeneous nuclear ribonucleoprotein Q to maintain proliferation of human colon cancer cells", Cell Mol Life Sci, 66(2), pp.350~364 (2009)
- Miyazaki J., "Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes", Oncol Rep, 9(6), pp.1307~1312 (2002)
- Castronovo V., "Decreased expression of galectin-3 is associated with progression of human breast cancer", J Pathol, 179(1), pp.43~48 (1996)
- Van den Brule FA., "Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas", Eur J Cancer, 30(8), pp.1096~1099 (1994)
- Pacis RA., "Decreased galectin-3 expression in prostate cancer", Prostate, 44(2), pp.118~123 (2000)
- Mollenhauer J., "Frequent down-regulation of DMBT1 and galectin-3 in epithelial skin cancer", Int J Cancer, 105(2), pp.149~157 (2003)
- Choufani G., "The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers", Cancer, 86(11), pp.2353~2363 (1999)
- 김원재, "Inhibition of cell motility and invasion by HangAmDan-B in NCI-H460 human non-small cell lung cancer cells", ONCOLOGY REPORTS, 26(6), pp.1601~1608, PROFESSOR D A SPANDIDOS
- 유화승, "Anti-angiogenic effects of the water extract of HangAmDan (WEHAD), a Korean traditional medicine", SCIENCE CHINA-LIFE SCIENCES, 54(3), pp.248~254, SCIENCE CHINA PRESS
- Park HM., "Integrative Tumor Board: A Case Report and Discussion From East-West Cancer Center", INTEGRATIVE CANCER THERAPIES, 9(2), pp.236~245 (2010), INTEGRATIVE CANCER THERAPIES
- 방지영, "Analysis of anti-angiogenic mechanism of HangAmDan-B (HAD-B), a Korean traditional medicine, using antibody microarray chip", BioChip Journal, 4(4), pp.350~355 (2010), 한국바이오칩학회
- 유화승, "A Toxicological Study of HangAmDan-B in Mice", Journal of Acupuncture & Meridian Studies, 4(1), pp.54~60 (2011), 사단법인약침학회
- Xu R., "Recent advances in the treatment of colon cancer", Histol Histopathol, 21(8), pp.867~872 (2006)
- Nordman IC., "Advances in the adjuvant treatment of colorectal cancer", ANZ J Surg, 76(5), pp.373~380 (2006)
- Li J., "Inhibition of autophagy by 3-MA enhances the effect of 5-FUinduced apoptosis in colon cancer cells", Ann Surg Oncol, 16(3), pp.761~771 (2009)
- Padgett CL., "GABAB receptor coupling to Gproteins and ion channels", Adv Pharmacol, 58, pp.123~147 (2010)
- Kaupmann K., "Expression cloning of GABA(B)receptors uncovers similarity to metabotropic glutamate receptors", Nature, 386(6622), pp.239~246 (1997)
- Kaupmann K., "GABA(B)-receptor subtypes assemble into functional heteromeric complexes", Nature, 396(6712), pp.683~687 (1998)
- Schuller HM., "Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma", Carcinogenesis, 29(10), pp.1979~1985 (2008)
- Thaker PH., "Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal", Cancer Biol Ther, 4(7), pp.753~758 (2005)
- Wan T., "Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo", Life Sci, 82(9-10), pp.536~541 (2008)
- Schuller HM., "GABA B receptor is a novel drug target for pancreatic cancer", Cancer, 112(4), pp.767~778 (2008)